ClinicalTrials.gg
Sign In

Vascular Diseases clinical trials

The registry lists 694 studies for Vascular Diseases across more than 10 countries. 128 are recruiting or about to start. 142 of them are mainly about Vascular Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 166 narrower conditions too, such as Stroke: 49,492 studies, 10,520 open.

ClinicalTrials.gov finds 49,490 studies for Vascular Diseases. How that becomes 694 here

This page counts the studies the registry files under Vascular Diseases, and those it files under no condition that list Vascular Diseasesthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 49,490Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −45,212Filed under a narrower condition, counted on its own pageStroke 7,751 · Hypertension 5,667 · Coronary Artery Disease 4,515 · Multiple Myeloma 3,660 · Ischemic Stroke 1,707 · Myocardial Infarction 1,410 · 150 more
  3. −58List Vascular Diseases as a condition, but the registry did not file them under itMost often written as “Cardio Vascular Disease” (23), “Pulmonary Vascular Disease” (6), and “Cardio-vascular Disease” (3). The registry filed 21 of them under no condition at all, and the others under other conditions only, most often Cardiovascular Diseases (6) and Idiopathic Noncirrhotic Portal Hypertension (5).
  4. −3,526Match it another way49 name it in the title, 8 in a keyword, and 3,469 by a synonym or other text the search reads.
  5. 694The count on this page

Get an email when these change. Save the Vascular Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
381
Recruiting
95
Status unknown
79
Terminated
41
Active, not recruiting
39
Not yet recruiting
25

Phase

Phase 2
78
Phase 3
68
Phase 4
48
Phase 1
37
Early Phase 1
6

Where

United States
243
Germany
77
France
69
United Kingdom
62
China
53
Canada
45

Who runs them

Abbott Medical Devices (26) · National Heart, Lung, and Blood Institute (NHLBI) (25) · Medtronic Vascular (12) · Brigham and Women's Hospital (8) · Takeda (8) · W.L.Gore & Associates (7) · Cook Research Incorporated (6) · Assistance Publique - Hôpitaux de Paris (6)

What is being tested here

Drugs under test in Vascular Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Mosliciguat213
Aspirin116
Nicotinamide-beta-riboside102
Ralinepag122
Tenecteplase112
Rivaroxaban102
Norepinephrine102
Genistein101
Montelukast101
TA-65101

Drug classes tested here Statins 1 open · Thrombolytics 1 open · Factor Xa inhibitors 1 open · Angiotensin receptor blockers (ARBs) 8 · P2Y12 inhibitors 7

Coming up

8phase 3 studies under way
35studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 95 Vascular Diseases studies recruiting now, 59 (62%) set no upper age limit and 13 (14%) stop at 75 or younger. 7 (7%) take children under 18. 3 (3%) are for women only and 0 (0%) for men only; 14 (15%) take healthy volunteers.

Recruiting studies that take each age, of 95
AgeWomenMen
107 (7%)7 (7%)
1884 (88%)82 (86%)
3089 (94%)86 (91%)
4090 (95%)87 (92%)
5090 (95%)88 (93%)
6590 (95%)89 (94%)
7585 (89%)85 (89%)
8576 (80%)76 (80%)

Across all 694 studies, recruiting or not: 20% stop at 75 or younger and 10% at 65; 9% take children; 3% are for women only and 2% for men only; 17% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Vascular Diseases studies take

Of 19 phase 2 interventional studies under Vascular Diseases, half reached primary completion within 44 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 118 mo3–45 · 16 studies——
Phase 244 mo19–73 · 19 studies——
Phase 340 mo24–78 · 19 studies——
Phase 456 mo25–84 · 16 studies——
Interventional, no phase33 mo19–57 · 147 studies41 mo22–58 · 44 studies30 mo17–57 · 103 studies
Observational52 mo25–128 · 100 studies—67 mo30–167 · 75 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting2

Newly registered3

Studies

Recruiting first, then most recently updated. Showing 50 of 694. Browse all 694 → or search them.